Clinical trials
Hypertrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
139 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 5 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 9 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 10 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 11 |
| 2024 | 11 |
| 2025 | 9 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 82 |
| Unknown status | 27 |
| Recruiting | 11 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 4 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AVAVA, Inc. | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Paulista University | 3 |
| David Smart | 2 |
| Karabuk University | 2 |
| Lindenwood University | 2 |
| Marymount University | 2 |
| McMaster University | 2 |
| Neodyne Biosciences, Inc. | 2 |
| University of British Columbia | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertrophy | 139 |
| Cicatrix | 13 |
| Hypertrophy, Left Ventricular | 10 |
| Cardiomyopathies | 9 |
| Cardiomyopathy, Hypertrophic | 8 |
| Heart Failure | 7 |
| Cardiovascular Diseases | 6 |
| Hypertension | 5 |
| Carcinoma, Hepatocellular | 4 |
| Keloid | 4 |
Trials
Showing 76 to 100 of 139. Each trial links to its page on Pharma Observatory.
39 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.